Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.
N Engl J Med. 2001 Jul 26;345(4):241-7. doi: 10.1056/NEJM200107263450402.
N Engl J Med. 2001.
PMID: 11474661
Clinical Trial.